Status:
UNKNOWN
Follow-up of COVID-19 Vaccine Response in Strasbourg University Hospitals
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
COVID-19 Vaccines
Eligibility:
All Genders
18+ years
Brief Summary
Vaccination remains the main promising measure to fight against the COVID-19 pandemic. The presumed efficacy of the vaccines is quite remarkable since it varies between 62 and 95%. There is increasing...
Eligibility Criteria
Inclusion
- \- Any person, male or female, over 18 years of age who underwent vaccination and
- anti-SARS-CoV-2 serological test after vaccination
- having already given their consent for their biological resources to be:
- stored in a biocollection of the Microbiology Technical Platform (PTM) having received an approval from the CPP Est-IV and declared to the Ministry of Education and Research under reference No. DC2009-1002;
- subsequently reused, as well as the anonymized associated data, for research purposes
Exclusion
- Inability to give clear information (person in an emergency, difficulty understanding the subject, etc.)
- Person under safeguard of justice
- Person under guardianship or curatorship-
Key Trial Info
Start Date :
April 30 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT04852835
Start Date
April 30 2021
End Date
December 31 2023
Last Update
December 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Virologie - Hôpital Civil
Strasbourg, France, 67091